Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Cannara Biotech Inc (OP: LOVFF ) 0.4502 -0.0017 (-0.38%) Streaming Delayed Price Updated: 10:41 AM EST, Nov 11, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 36,000 Open 0.4519 Bid (Size) N/A (0) Ask (Size) N/A (0) Prev. Close 0.4519 Today's Range 0.4502 - 0.4519 52wk Range 0.3971 - 0.7750 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Canada's Cannabis Market Goes Cold, Pot Prices Hit Bottom: Why Top Producers Are Losing Ground October 29, 2024 Amid this slowdown, certain products capture consumer interest, even as prices stabilize and competition intensifies. Via Benzinga Topics Cannabis Exposures Cannabis Cannara Biotech Reports 6% YoY Drop In Q3 Gross Profit, 22% Revenue Increase As It Enhances Sales Force And Infrastructure July 23, 2024 Vertically integrated cannabis company Cannara Biotech Inc. (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0) announced on Tuesday its fiscal third quarter 2024 financial and operating results for the three and... Via Benzinga Topics Cannabis Exposures Cannabis Performance YTD -27.92% -27.92% 1 Month +3.83% +3.83% 3 Month -16.44% -16.44% 6 Month -25.41% -25.41% 1 Year -33.85% -33.85% More News Read More Cannara Biotech Reports Q3 2024 Financial Results July 23, 2024 From Cannara Biotech (Québec) Inc. Via GlobeNewswire Cannabis Slowdown In Canada: Analyst Spotlights What Still Sells And Where The Money Is Going June 03, 2024 Via Benzinga Topics Cannabis Exposures Cannabis Cannara Biotech Reports 51% YoY Revenue Increase In Q2, Wider Net Loss May 01, 2024 Via Benzinga Topics Cannabis Exposures Cannabis This Cannabis Producer Reports It Is Able to Deliver Some Of The Highest Quality Product To Market At Some Of The Most Competitive Prices December 20, 2023 Via News Direct Topics Cannabis Exposures Cannabis The 7 Most Undervalued Cannabis Stocks to Buy in December December 14, 2023 Via InvestorPlace Topics Cannabis Exposures Cannabis This Cannabis Producer Reports It Is Able to Deliver Some Of The Highest Quality Product To Market At Some Of The Most Competitive Prices December 07, 2023 Via Benzinga Topics Cannabis Exposures Cannabis Bearish Sentiment Across The Cannabis Space - Check Full Movers For August 21, 2023 August 21, 2023 Via Benzinga Topics Cannabis Exposures Cannabis 7 Smoking-Hot 420 Stocks to Buy in 2023 August 17, 2023 Via InvestorPlace Topics Cannabis Exposures Cannabis Cannabis Stock Movers For August 10, 2023 August 10, 2023 Via Benzinga Topics Cannabis Exposures Cannabis Cannara Biotech Q3 FY23 Net Revenue Grows 57% YoY, What About Adjusted EBITDA? July 27, 2023 Via Benzinga Cannabis Stock Gainers And Losers From August 4, 2023 August 04, 2023 Via Benzinga Cannabis Stock Gainers And Losers From July 25, 2023 July 25, 2023 Via Benzinga Marijuana Stock Movers For August 1, 2023 August 01, 2023 Via Benzinga Cannara Biotech Secures An Additional $10M In Non-Dilutive Capital With Its Lead Credit Provider, BMO Commercial Banking May 04, 2023 Via Benzinga Cannara Biotech Q2 FY23 Revenue Grows 76% YoY To $9.6M, Here Are The Details April 24, 2023 Via Benzinga Cannabis Stock Movers For July 27, 2023 July 27, 2023 Via Benzinga Olymbec Investments Increases Its Ownership In Cannara Biotech February 10, 2023 Via Benzinga Cannara Biotech Q1 Revenue Grows 57% YoY To $7.7M, What About Adjusted EBITDA? January 23, 2023 Via Benzinga Cannara Biotech Q4 Revenue Grows 84% YoY To $8.9M November 28, 2022 Via Benzinga Cannara Biotech Enters Into The British Columbia Cannabis Market And Launches New Products September 20, 2022 Via Benzinga Cannara Biotech Signs An Exclusive Brand Partnership With Exotic Genetix In Canada August 03, 2022 Via Benzinga Cannara Biotech Revenue Grows 41% YoY, Here Are The Details July 27, 2022 Via Benzinga Cannara Biotech Closes $50 Million Credit Facility Led By BMO Commercial Banking June 02, 2022 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
